Literature DB >> 9497049

Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.

A V Pandey1, R Joshi, B L Tekwani, R L Singh, V S Chauhan.   

Abstract

Synthetic peptides containing a repetitive hexapeptide sequence (Ala-His-His-Ala-Ala-Asp) of malarial histidine-rich protein II were evaluated for binding with haem in vitro. The pattern of haem binding suggested that each repeat unit of this sequence provides one binding site for haem. Chloroquine inhibited the haem-peptide complex formation with preferential formation of a haem chloroquine complex. In vitro studies on haem polymerisation showed that none of the peptides could initiate haemozoin formation. However, they could inhibit haemozoin formation promoted by a malarial parasite extract, possibly by competitively binding free haem. These results indicate this hexapeptide sequence represents the haem binding site of the malarial histidine-rich protein and possibly the site of nucleation for haem polymerisation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9497049     DOI: 10.1016/s0166-6851(97)00161-8

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  3 in total

1.  Mechanism of malarial haem detoxification inhibition by chloroquine.

Authors:  A V Pandey; H Bisht; V K Babbarwal; J Srivastava; K C Pandey; V S Chauhan
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  The efficacy of inhibitors involved in spermidine metabolism in Plasmodium falciparum, Anopheles stephensi and Trypanosoma evansi.

Authors:  E Moritz; S Seidensticker; A Gottwald; W Maier; A Hoerauf; J T Njuguna; A Kaiser
Journal:  Parasitol Res       Date:  2004-07-29       Impact factor: 2.289

3.  Quantification of labile heme in live malaria parasites using a genetically encoded biosensor.

Authors:  James R Abshire; Christopher J Rowlands; Suresh M Ganesan; Peter T C So; Jacquin C Niles
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-27       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.